Which patent foramen ovale needs to be closed, and how?;Quels foramens ovales perméables faut-il fermer et comment?

Annales de Cardiologie et d'Angeiologie

Volumn 60, Issue 6, 2011, Pages 366-372

  Brasselet, C ^a   Duval, S ^a  

^a Polyclinique de Courlancy   (France)

Author keywords

Patent foramen ovale; Percutaneous closure

Indexed keywords

CARDIOVASCULAR SURGERY; HUMAN; MIGRAINE AURA; PATENT FORAMEN OVALE; PATENT FORAMEN OVALE CLOSURE; SHORT SURVEY; STROKE; SURGICAL TECHNIQUE; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; ULTRASOUND; X RAY;

BALLOON DILATION; EVIDENCE-BASED MEDICINE; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MIGRAINE DISORDERS; PRACTICE GUIDELINES AS TOPIC; PROSTHESES AND IMPLANTS; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 82255175601     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2011.09.003     Document Type: Short Survey

References (34)

1. Hagen P.T., Scholz D.G., Edwards W.D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
2. Madani H., Ransom P.A. Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism. Emerg Med J 2007, 24:441.
3. Ahmed S., Sadiq A., Siddiqui A.K., Borgen E., Mattana J. Paradoxical arterial emboli causing acute limb ischemia in a patient with essential thrombocytosis. Am J Med Sci 2003, 326:156-158.
4. Ludman PF on behalf of the British Cardiovascular Intervention Society. BCIS Audit Returns. Adult Interventional Procedures 2008, online.
5. Lechat P., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988, 318:1148-1152.
6. Di Tullio M., Sacco R.L., Gopal A., Mohr J.P., Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992, 117:461-465.
7. Cabanes L., et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993, 24:1865-1873.
8. Overell J.R., Bone I., Lees K.R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172-1179.
9. Handke M., Harloff A., Olschewski M., Hetzel A., Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007, 357:2262-2268.
10. Foulkes M.A., Wolf P.A., Price T.R., Mohr J.P., Hier D.B. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988, 19:547-554.
11. Zahn F.W. Thrombose de plusieurs branches de la veine cave inférieure avec embolies consécutives dans les artères pulmonaire, splénique, rénale et iliaque droite. Rev Med Suisse Romande 1881, 1:227-237.
12. Cramer S.C., et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004, 35:46-50.
13. Kim R.J., Girardi L.N. Lots of clots": multiple thromboemboli including a huge paradoxical embolus in a 29-year-old man. Int J Cardiol 2008, 129:e50-e52.
14. Rigatelli G., et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?. JACC Cardiovasc Interv 2009, 2:655-662.
15. Homma S., Sacco R.L., Di Tullio M.R., Sciacca R.R., Mohr J.P. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 2002, 105:2625-2631.
16. Bridges N.D., et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992, 86:1902-1908.
17. Khairy P., O'Donnell C.P., Lanzberg M.J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003, 139:753-760.
18. Windecker S., et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004, 44:750-758.
19. Furlan AJ, for the CLOSURE I Investigators. A prospective, multicenter, randomized controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Presented at the American Heart Association Meeting, 15th November 2010.
20. Rigatelli G., et al. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts. Cardiovasc Revasc Med 2007, 8:248-250.
21. Mehan V.K., Wahl A., Walpoth N., Meier B. Instant percutaneous closure of patent foramen ovale in patients with acute myocardial infarction and normal coronary arteries. Catheter Cardiovasc Interv 2006, 67:279-282.
22. Butler B.D., Hills B.A. The lung as a filter for microbubbles. J Appl Physiol 1979, 47:537-543.
23. Moon R.E., Camporesi E.M., Kisslo J.A. Patent foramen ovale and decompression sickness in divers. Lancet 1989, 1:513-514.
24. Wilmshurst P.T., Byrne J.C., Webb-Peploe M.M. Neurological decompression sickness. Lancet 1989, 1:731.
25. Wilmshurst P.T., Byrne J.C., Webb-Peploe M.M. Relation between interatrial shunts and decompression sickness in divers. Undersea Biomed Res 1990, 16:147-153.
26. Wilmshurst P., Bryson P. Relationship between the clinical features of neurological decompression illness and its causes. Clin Sci 2000, 99:65-75.
27. Toerti P., et al. Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004, 25:1014-1020.
28. Wilmshurst P., Walsh K., Morrison L. Transcatheter occlusion of foramen ovale with a button device after neurological decompression illness in professional divers. Lancet 1996, 348:752-753.
29. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657.
30. Anzola G.P., Frisoni G.B., Morandi E., Casilli F., Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006, 37:430-434.
31. Wilmshurst P.T., Nightingale S., Walsh K.P., Morrison W.L. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356:1648-1651.
32. Dowson A., et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008, 117:1397-1404.
33. Almange C, Schleich JM, Du Haut Cilly F, Boulmier D, Laurent M. Syndrome de platypnée-orthodéoxie: diagnostic, étiologie, traitement. Arch Mal Coeur Vaiss 2002;95:507-11.
34. Hildick-Smith D., Behan M., Haworth P., Rana B., Thomas M. Patent foramen ovale closure without echocardiographic control: use of " standby" intracardiac ultrasound. JACC Cardiovasc Interv 2008, 1:387-391.